Hjem › Glioblastom › Ohio › Columbus
Kliniske studier for Glioblastom i Columbus, OH
14 studier for Glioblastom søker deltakere på steder i og rundt Columbus (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.
Offisiell studietekst (engelsk)
Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →
Testing the Addition of an Anti-cancer Drug, Selinexor, to the Usual Chemotherapy Treatment (Temozolomide) for Brain Tumors That Have Returned After Previous Treatment
RekruttererFase 1/2
- Ohio State University Comprehensive Cancer Center, Columbus
Study of Silevertinib With Temozolomide for the Treatment of Newly Diagnosed GBM With Unmethylated MGMT and EGFRvIII
RekruttererFase 2
- Ohio State University, Columbus
Beginning Radiation Immediately With GammaTile at GBM Excision Versus Standard of Care
RekruttererFase 3
- The Ohio State University, Columbus
Targeted Pediatric High-Grade Glioma Therapy
RekruttererObservasjonsstudie
- Nationwide Children's Hospital, Columbus
Testing the Addition of an Anti-Cancer Drug, Triapine, to the Usual Radiation Therapy for Recurrent Glioblastoma or Astrocytoma
RekruttererFase 1
- Ohio State University Comprehensive Cancer Center, Columbus
Study of Olutasidenib and Temozolomide in HGG
RekruttererFase 2
- Nationwide Children's Hospital, Columbus
Alpha Radiation Emitters Device (DaRT) for the Treatment of Recurrent Glioblastoma
Rekrutterer
- Ohio State University Medical Center, Columbus
Adjuvant Temozolomide ± 5-Aminolevulinic Acid + Low Intensity Diffuse Ultrasound Sonodynamic Therapy System for Newly Diagnosed Glioblastoma
RekruttererFase 2
- Ohio State University, Columbus
DOC1021 Dendritic Cell Immunotherapy for Treatment of Newly Diagnosed Adult Glioblastoma (GBM)
RekruttererFase 2
- The Ohio State University Comprehensive Cancer Center, Columbus
Lorlatinib for Newly-Diagnosed High-Grade Glioma With ROS or ALK Fusion
RekruttererTidlig fase 1Frivillige helsepersonell ønskes velkommen
- Nationwide Children's Hospital, Columbus
Study of an AAV Mediated Dual-Payload Gene Therapy in Patients With High Grade Glioma
RekruttererFase 1/2
- Ohio State University Hospital, Columbus
Study of Ribociclib and Everolimus in HGG and DIPG or Ribociclib and Temozolomide in DHG, H3G34-mutant
RekruttererFase 2
- Nationwide Children's Hospital, Columbus
Safety and Tolerability of TNG456 Alone and in Combination With Abemaciclib in Patients With Solid Tumors With MTAP Loss
RekruttererFase 1/2
- Ohio State University Comprehensive Cancer Center, Columbus
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
RekruttererObservasjonsstudie
- Massive Bio SYNERGY-AI site, Columbus
Glioblastom-studier i andre byer
- New York City, NY30 studier
- Boston, MA28 studier
- Houston, TX25 studier
- Los Angeles, CA23 studier
- Durham, NC20 studier
- San Francisco, CA17 studier
- Washington, DC15 studier
- Chicago, IL15 studier
- Rochester, MN15 studier
- Miami, FL14 studier
- Jacksonville, FL13 studier
- Aurora, CO12 studier
Andre studier i Columbus
- Ikke-småcellet lungekreft56 studier
- Brystkreft39 studier
- Eggstokkreft39 studier
- Kreft (alle typer)38 studier
- Lungekreft37 studier
- Akut myelogen leukemi35 studier
- Kronisk lymfatisk leukemi28 studier
- Metastatisk kreft27 studier
- Endometriekreft25 studier
- Kolorektal kreft24 studier
- Prostatakreft24 studier
- Multipelt myelom24 studier
Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.